Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid

American Journal of Surgical Pathology

Volumn 20, Issue 6, 1996, Pages 686-694

  Papotti, M ^a   Torchio, B ^b   Grassi, L ^a   Favero, A ^b   Bussolati, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

Author keywords

Hurthle cell; Neoplasm; Oxyphilic cell; Poorly differentiated carcinoma; Thyroid

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CELL DIFFERENTIATION; HUMAN; HUMAN TISSUE; THYROID CARCINOMA; THYROID PARAFOLLICULAR CELL;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PROGNOSIS; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 0029919144     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199606000-00005     Document Type: Article

References (21)

1. Arganini M, Behar R, Wu TC. Hurthle cell tumors: a 25-year experience. Surgery 1986;100:1108-15.
2. Bondeson L, Azavedo E, Bondeson AG, Caspersson T, Ljungberg O. Nuclear DNA content and behavior of oxyphil thyroid tumors. Cancer 1986;58:672-5.
3. Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J. Follicular Hurthle cell tumors of the thyroid gland. Cancer 1991;68:1944-53.
4. Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 1985;83:135-58.
5. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ("insular") thyroid carcinoma: a reinterpretation of Langhans' wuchernde struma. Am J Surg Pathol 1984;8:655-68.
6. Carr K, Heffess C, Jin L, Lloyd RV. Immunocytochemical analysis of thyroid carcinomas utilizing antibodies to p53 and Ki-67. Appl Immunohistochem 1993;1:201-7.
7. Flint A, Lloyd RV. Hurthle cell neoplasms of the thyroid gland. Pathol Annu 1990;25:37-50.
8. Gonzales-Campora R, Herrero-Zapatero A, Lerma E, Sanchez F, Galera H. Hurthle cells and mitochondrion-rich cell tumors. Cancer 1986;57:1154-63.
9. Har-el G, Hadar T, Segal K, Levy R, Sidi J. Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer 1986;57:1613-7.
10. Hedinger CE. Histological typing of thyroid tumors. Berlin: Springer-Verlag, 1988:7-8.
11. Johnson TL, Lloyd RV, Burney LE, Thompson NW. Hurthle cell thyroid tumors. An immunohistochemical study. Cancer 1987;59:107-12.
12. LiVolsi VA. Surgical pathology of the thyroid. Philadelphia: WB Saunders Company, 1990:275-88.
13. Ljungberg O. Biopsy pathology of the thyroid and parathyroid. London: Chapman & Hall Medical. 1992:190-8.
14. Nesland JM, Sobrinho-Simoes MA, Holm R, Sambade MC, Johannessen JV. Hurthle cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy and immunohistochemistry. Ultrastruct Pathol 1985;8:269-90.
15. Papotti M, Botto-Micca F, Favero A, Palestini N, Bussolati G. Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular and solid patterns. Am J Surg Pathol 1993; 17:291-301.
16. Papotti M, Gugliotta P, Forte G, Bussolati G. Immunocytochemical identification of oxyphilic mitochondrion-rich cells. Appl Immunohistochem 1994;2:261-7.
17. Pezzella F, Gatter K. What is the value of bcl-2 protein detection for histopathologists? Histopathology 1995;26:89-93.
18. Rosai J, Carcangiu ML, De Lellis RA. Tumors of the thyroid gland. In: Atlas of tumor pathology. Washington: Armed Forces Institute of Pathology, 1992:161-82.
19. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high risk group of papillary and follicular carcinomas. Cancer 1983;52:1849-55.
20. Soares P, Cameselle-Teijeiro J, Sobrinho-Simoes M. Immunohistochemical detection of p53 in differentiated, poorly differentated and undifferentiated carcinomas of the thyroid. Histopathology 1994;24:205-10.
21. Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH. Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet 1974;139:555-60.